Amryt Pharma
$13.509876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$13.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.05 (-0.37%) Today
$0.00 (0.00%) As of 9:00 PM UTC after-hours
Why Robinhood?
You can buy or sell Amryt Pharma and other stocks, options, and ETFs commission-free!
About AMYT
Amryt Pharma plc American Depositary Shares, also called Amryt Pharma, is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. It operates through the following segments: Commercial, Research and Development. The Commercial segment includes the financial results of the Group's two current commercial product lines, Imlan and Lojuxta. The Research and Development segment comprises the financial results of the Group’s two current research and development assets, AP101 and AP102. The company was founded by Joseph Amrit Wiley and Rory Peter Nealon on August 28, 2015 and is headquartered in Dublin, Ireland. The listed name for AMYT is Amryt Pharma plc American Depositary Shares.
CEO
Joseph Wiley
Employees
—
Headquarters
Dublin, Dublin
Founded
2004
Market Cap
478.51M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
5.08K
High Today
$13.58
Low Today
$13.38
Open Price
$13.58
Volume
4.30K
52 Week High
$15.50
52 Week Low
$7.90
Collections
AMYT Earnings
-$0.87
-$0.58
-$0.29
-$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Available Mar 4, Pre-Market